| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |